Future studies in HIV-infected patients are required to determine sensitive ET-1 thresholds for earlier recognition of PAH and to assess if higher levels of ET-1 predict functional or clinical outcomes. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.